Healthtech Solutions, Inc./UT (HLTT) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
181 DANTE AVENUE TUCKAHOE, NY 10707 |
| State of Incorp. | UT |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 192 | 69 | 100 | 7 | 39 | 907 | |||
| Cash and cash equivalent | 192 | 69 | 100 | 7 | 39 | 907 | |||
| Receivables | 725 | 10 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 199 | ||||||||
| Inventory | 199 | ||||||||
| Prepaid expense | 212 | 384 | 431 | 138 | 81 | 158 | |||
| Intangible current assets | |||||||||
| Other undisclosed current assets | 0 | 168 | |||||||
| Total current assets: | 1,327 | 463 | 531 | 313 | 120 | 1,065 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 93 | 103 | |||||||
| Long-term investments and receivables | 110 | 110 | 110 | 110 | |||||
| Due from related parties | 110 | 110 | 110 | 110 | |||||
| Intangible assets, net (including goodwill) | 107 | 118 | 130 | 1,104 | 1,111 | ||||
| Goodwill | 1,104 | 1,104 | |||||||
| Intangible assets, net (excluding goodwill) | 107 | 118 | 130 | 6 | |||||
| Other undisclosed noncurrent assets | 0 | 113 | |||||||
| Total noncurrent assets: | 310 | 332 | 353 | 110 | 1,104 | 1,111 | |||
| Other undisclosed assets | (0) | ||||||||
| TOTAL ASSETS: | 1,637 | 795 | 884 | 423 | 1,225 | 2,176 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,981 | 1,321 | 988 | 734 | 174 | 160 | |||
| Accounts payable | 174 | 160 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 1,981 | 1,321 | 988 | 734 | |||||
| Due to related parties | 1,146 | 791 | 508 | 357 | 354 | ||||
| Other undisclosed current liabilities | 1,362 | 1,111 | 837 | 337 | 706 | 469 | |||
| Total current liabilities: | 4,489 | 3,223 | 2,333 | 1,071 | 1,237 | 983 | |||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 4,489 | 3,223 | 2,333 | 1,071 | 1,237 | 983 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (2,340) | (1,934) | (1,323) | (648) | (12) | 1,193 | |||
| Preferred stock | 0 | 0 | 0 | 0 | 0 | ||||
| Common stock | 70 | 67 | 67 | 67 | 29 | 29 | |||
| Additional paid in capital | 10,253 | 9,833 | 9,833 | 9,833 | 7,661 | 7,661 | |||
| Accumulated deficit | (12,663) | (11,834) | (11,223) | (10,548) | (7,708) | (6,506) | |||
| Other undisclosed equity, attributable to parent | (0) | (0) | (0) | 5 | 8 | ||||
| Equity, attributable to noncontrolling interest | (511) | (495) | (126) | 5 | |||||
| Other undisclosed equity | (10) | (8) | |||||||
| Total equity: | (2,851) | (2,429) | (1,449) | (648) | (18) | 1,184 | |||
| Other undisclosed liabilities and equity | 5 | 8 | |||||||
| TOTAL LIABILITIES AND EQUITY: | 1,637 | 795 | 884 | 423 | 1,225 | 2,176 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Other undisclosed loss before gain (loss) on sale of properties | ✕ | ✕ | ✕ | ✕ | (669) | ✕ | ✕ | |
| Revenues | 776 | |||||||
| Cost of revenue | (52) | |||||||
| Cost of product and service sold | ||||||||
| Gross profit: | 724 | |||||||
| Operating expenses | (1,569) | (980) | (2,032) | (1,205) | (1,506) | |||
| Other undisclosed operating income (loss) | (801) | 2,941 | ||||||
| Operating loss: | (845) | (980) | (801) | (2,032) | (1,205) | (1,506) | ||
| Nonoperating income (expense) | 6,602 | (3,269) | ||||||
| Other nonoperating expense | (3,269) | |||||||
| Income (loss) from continuing operations: | (845) | (980) | (801) | 4,570 | (1,205) | (4,775) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (845) | (980) | (801) | 3,901 | (1,205) | (4,775) | |
| Other undisclosed net loss | (6,736) | |||||||
| Net loss: | (845) | (980) | (801) | (2,835) | (1,205) | (4,775) | ||
| Net income (loss) attributable to noncontrolling interest | 109 | 215 | 675 | |||||
| Other undisclosed net income (loss) attributable to parent | (0) | (675) | 0 | |||||
| Net loss attributable to parent: | (736) | (765) | (801) | (2,835) | (1,205) | (4,775) | ||
| Other undisclosed net loss available to common stockholders, basic | (109) | (215) | ||||||
| Net loss available to common stockholders, diluted: | (845) | (980) | (801) | (2,835) | (1,205) | (4,775) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (845) | (980) | (801) | (2,835) | (1,205) | (4,775) | ||
| Comprehensive loss: | (845) | (980) | (801) | (2,835) | (1,205) | (4,775) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 109 | 215 | 675 | |||||
| Comprehensive loss, net of tax, attributable to parent: | (736) | (765) | (126) | (2,835) | (1,205) | (4,775) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.